This is a preview of subscription content, log in via an institution to check access.
Reference
Kwong WJ, et al. Resource Use and Cost Implications of Switching Among Warfarin Formulations in Atrial Fibrillation Patients. Annals of Pharmacotherapy 46: 13 Nov 2012. Available from: URL: http://dx.doi.org/10.1345/aph.1Q472
Additional information
* funded by Daiichi Sankyo, Inc.
Rights and permissions
About this article
Cite this article
Switching warfarin formulations cost saving?. PharmacoEconomics & Outcomes News 668, 8 (2012). https://doi.org/10.1007/s40274-012-0023-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-012-0023-9